←
CLINICAL TRIAL OF THE DAY936 posts
CLINICAL TRIAL OF THE DAY avatar

CLINICAL TRIAL OF THE DAY

@mdwrtcom

Here, is the CLINICAL TRIAL OF THE DAY The interesting clinical study with impact on future clinical practice // Our editor's opinion only //

◷ Joined April 2022▧ 369 Photos and videos
CLINICAL TRIAL OF THE DAY avatar
CLINICAL TRIAL OF THE DAY@mdwrtcom·31 Oct 2023

EV-302/KEYNOTE-A39: #enfortumab vedotin + #pembrolizumab improved overall survival by 53% compared to platinum-based chemotherapy in urothelial #cancer

Post attachment
Tom Powles@tompowles122 Oct 2023

Enfortumab vedotin & Pembrolizumab improving PFS & OS by 55% & 53% respectively compared to platinum based chemo in 1st line UC (+avelumab in 30%). Chemo has not been beaten before (despite multiple efforts). RR and CR of 68% & 29% is hard to beat. DOR not reached (1/3)#ESMO2023

Post attachmentPost attachmentPost attachmentPost attachment